IRIS
FABRIS, Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.511
EU - Europa 1.947
AS - Asia 1.254
SA - Sud America 196
AF - Africa 37
OC - Oceania 6
Totale 8.951
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.466
SG - Singapore 669
IT - Italia 484
UA - Ucraina 386
DE - Germania 288
CN - Cina 245
RU - Federazione Russa 212
BR - Brasile 174
FI - Finlandia 122
IE - Irlanda 116
GB - Regno Unito 81
SE - Svezia 73
VN - Vietnam 72
TR - Turchia 68
IN - India 64
FR - Francia 54
KR - Corea 40
HK - Hong Kong 36
AT - Austria 35
CA - Canada 31
BE - Belgio 21
ES - Italia 17
IR - Iran 15
NL - Olanda 13
TG - Togo 11
ZA - Sudafrica 9
MX - Messico 8
JP - Giappone 7
RO - Romania 7
AU - Australia 6
EG - Egitto 6
PL - Polonia 6
AE - Emirati Arabi Uniti 5
AR - Argentina 5
CZ - Repubblica Ceca 5
MA - Marocco 5
BO - Bolivia 4
IQ - Iraq 4
KG - Kirghizistan 4
RS - Serbia 4
BD - Bangladesh 3
EC - Ecuador 3
PK - Pakistan 3
AL - Albania 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
TH - Thailandia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
LI - Liechtenstein 1
LK - Sri Lanka 1
NO - Norvegia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 8.951
Salva come PNG Salva come JPEG
Città #
Woodbridge 655
Fairfield 556
Chandler 534
Singapore 437
Ann Arbor 403
Houston 382
Ashburn 297
Jacksonville 250
Wilmington 245
Seattle 228
Dearborn 187
Cambridge 167
Boardman 152
Udine 141
Beijing 113
Dublin 111
Princeton 103
Dong Ket 70
Izmir 66
Redmond 55
San Diego 46
Trieste 43
Munich 36
Seoul 35
Hong Kong 32
Venezia 29
Los Angeles 26
Ogden 26
Norwalk 25
Des Moines 24
Belluno 23
Brussels 21
Düsseldorf 21
Nuremberg 21
Nanjing 20
New York 19
Ottawa 19
Santa Clara 19
Guangzhou 16
Leawood 14
Milan 14
São Paulo 14
Hefei 13
Lauterbourg 13
San Mateo 13
Grafing 12
Vienna 12
Codroipo 11
Helsinki 11
Lomé 11
London 11
Augusta 10
Dallas 10
Tavagnacco 10
Frankfurt am Main 9
Rome 9
Ansbach 8
Auburn Hills 8
Hyderabad 8
Kunming 8
Lappeenranta 8
Phoenix 7
Portsmouth 7
Rio de Janeiro 7
Venice 7
Amsterdam 6
Boston 6
Gradisca d'Isonzo 6
Mumbai 6
Pune 6
Ribeirão Preto 6
Salvador 6
Toronto 6
Ardabil 5
Brasília 5
Johannesburg 5
Monmouth Junction 5
Montreal 5
Naples 5
Redwood City 5
Sydney 5
Valencia 5
Verona 5
Belgrade 4
Bishkek 4
Brno 4
Cairo 4
Cinisello Balsamo 4
Edinburgh 4
Falls Church 4
La Paz 4
Mexico City 4
Monza 4
Newark 4
San Francisco 4
San Vito al Tagliamento 4
Shanghai 4
Shenyang 4
Treviso 4
Warsaw 4
Totale 6.084
Salva come PNG Salva come JPEG
Nome #
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies 216
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis 198
Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes 174
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 166
Twist is substrate for caspase cleavage and proteasome-mediated degradation 160
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 152
Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients 150
Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients 143
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 137
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 136
Exploring the Possible Prognostic Role of B-Lymphocyte Stimulator (BLyS) in a Large Series of Patients with Neuroendocrine Tumors 134
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 131
Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells 130
BLyS and April serum levels in patients with autoimmune thyroid diseases. 128
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! 128
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 123
The role of B-lymphocyte stimulator in neuroendocrine tumors: Correlation with tumor differentiation, disease status and the presence of metastases 123
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 123
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 122
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 120
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared 120
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 118
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 116
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 116
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease 114
The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation 113
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 111
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 100
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease 99
Epidemiology of paraneoplastic neurological syndromes: a population-based study 98
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 94
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 94
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Gonarthrosis. 92
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 90
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes 90
HCV-NS3 and IgG-Fc crossreactive IGM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations 89
Clinical applications of microenvironment-controlled immunosuppressive properties of mesenchymal stem cells-derived exosomes: a review 89
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 88
Pharmacogenetic Determinants of Response to Infliximab in Pediatric Inflammatory Bowel Disease. 88
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 87
Rituximab in mixed cryoglobulinemia: increased experience and perspectives 81
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 81
TNF-alpha gene polymorphisms in rheumatoid arthritis patient treated with anti-TNF- alpha agents: preliminary results 80
Blys Promoter Polymorphism And Response To Rituximab In Rheumatoid Arthritis (RA) Patients Positive Or Negative For The Rheumatoid Factor 80
Preliminary classification of nonmalignant B cell proliferation in Sjögren’s syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach. Blood Cells, Molecules and Diseases 2001; 27: 757-66 (IF 1.703) 80
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 78
B-Lymphocyte Stimulator in neuroendocrine tumors: correlation with disease behaviour. 78
Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes 78
Asymmetrical Dimethylarginine (ADMA) In Asympomatic Cerebral Small Vessel Disease. 77
Do circulating exosomes interfere with vedolizumab efficacy in IBD patients? 76
The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers. 75
Comparison between Anti-β2Glycoprotein I Antibody and Anti-Phosphatidylserine/Prothrombin Antibody Biological Effects on Peripheral Blood Monocytes 75
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 75
Chlamydophila psittaci subclinical infection in chronic polyarthritis 74
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? 73
Detection of DNA of Chlamydophila psittaci in subjects with psoriasis: a casual or a causal link? 73
Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome. 73
Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study 71
The role of tumor-derived exosomes in cancer immune evasion mediated by toll-like receptor 4 activation 71
Characterization of Parotid Gland Epithelial Cell Primary Cultures from Patients Affected by Sjogren’s Syndrome 71
-238 AND +489 TNF-ALPHA ALONG WITH TNF-RII GENE POLYMORPHISMS ASSOCIATE WITH THE DIFFUSE PHENOTYPE IN PATIENTS WITH SYSTEMIC SCLEROSIS 68
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 68
B-Lymphocyte Stimulator (BLyS) upregulation in mixed cryoglobulinemia syndrome and hepatitis C virus infection 66
Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity is Significantly Associated with High Risk Anti-Phospholipid Antibody Antigenic Specificities . 64
Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report 63
The immunomodulatory properties of adipose mesenchymal stem cell-derived exosomes are induced by inflammatory cytokines . 63
SYSTEMIC CONNECTIVE TISSUE DISEASE COMPLICATED BY CASTLEMAN'S DISEASE: REPORT OF A CASE AND REVIEW OF THE LITERATURE 62
Tumor necrosis factor-alpha gene polymorphism in severe and mild -moderate rheumatoid arthritis. 61
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 61
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 61
Circulating exosomes express α4β7 integrin and compete with CD4+ T cells for the binding to Vedolizumab 60
The Effect of Osteoarthritic Synovial Fluid on Immunomodulatory Properties of Adipose Mesenchymal Stem Cells. 59
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 59
Anti-phosphatidylserine/prothrombin Autoantibodies Significantly Improve The Laboratory Diagnostic Process Of Anti-phospholipids Antibody Syndrome. 58
Serum levels of anti-CPP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab 57
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients 56
The Effect of Serum of Cerebral Small Vessel Disease Patients on Brain Endothelial Cells 55
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 55
The Exposure to Osteoarthritic Synovial Fluid Enhances the Immunomodulatory Profile of Adipose Mesenchymal Stem Cell Secretome 54
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study 53
Extracellular vesicle features are associated with COVID-19 severity 52
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 52
High prevalence of Chlamydophila Psittaci subclinical infection in Italian patients with Sjogren's syndrome and parotid gland B-cell lymphoma 50
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 49
Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism 49
Preliminary Evaluation of a new immunofluorescence mosaic assay for inflammatory bowel disease diagnosis: a pilot study in Udine 49
Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: Association with nephritis RID A-8026-2008 48
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFalpha agents failed are associated with response to rituximab in rheumatoid arthritis 48
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 48
Rituximab treatment for Glomerulonephritis in HCV-associated Mixed Cryoglobulinemia: efficacy and safety in the lack of steroids 47
A Multiparametric Method Improves the Serological Characterization of Inflammatory Bowel Diseases: Preliminary Results from a Multicenter Eastern Europe Study 46
Authors’ Reply to Cattaneo et al.: “Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6” 46
An overview on advantages and limitations of serological assays for saRs-coV-2 infectious disease 45
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients 45
Long-Term Effects of Rituximab in Rheumatoid Arthritis Clinical, Biologic, and Pharmacogenetic Aspects 44
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 43
Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6 42
Icatibant in severe acute respiratory syndrome coronavirus 2 infection: A case report 42
Type II mixed cryglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses 41
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection 39
Totale 8.548
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020148 0 0 0 0 0 0 0 0 0 0 42 106
2020/20211.175 32 127 16 139 33 134 55 119 202 47 157 114
2021/2022894 56 83 32 70 41 25 41 46 10 126 232 132
2022/20231.236 125 101 9 193 102 298 23 109 159 15 54 48
2023/2024407 53 25 22 12 60 55 13 45 44 41 10 27
2024/20252.027 72 167 204 115 111 117 200 157 288 225 371 0
Totale 9.300